Skip to main content
FDA to hold workshop for cancer patient advocates

The FDA Oncology Center of Excellence is holding a workshop Nov. 27 to teach cancer patient advocates about the FDA's mission of ensuring access to safe and effective treatments, writes Paul Kluetz, acting associate director of patient outcomes at the center. Topics include cancer treatment diagnosis, development, drugs and devices; the role of patient advocates in supporting the FDA's mission; and clinical trial endpoint terminology.

Full Story: